title: The resistance phenotype in the development and treatment of cancer.
abstract: Phenotypic resistance, acquired early in carcinogenesis, has an established role in the pathogenesis of cancer in well-characterised experimental systems, and possibly also has a role in the origin of human cancer. It has been suggested that sunlight, an established risk factor for human skin carcinogenesis, is able to induce rare altered cells resistant to toxicity and to favour their clonal expansion via toxic effects exerted on normal keratinocytes. Other major risk factors for human neoplasia, including smoking and ageing, may also act partly through imposition of a constrained growth environment in the target organ to favour the emergence of altered resistant cells. Strategies aimed at counteracting this constrained environment could be effective in attenuating the force that sustains clonal expansion of altered cells.
authors.affiliation: Department of Medical Sciences and Biotechnology, University of Cagliari, Italy. elaconi@vaxca1.unica.it
authors.forename: E
authors.initials: E
authors.lastname: Laconi
authors.forename: P
authors.initials: P
authors.lastname: Pani
authors.forename: E
authors.initials: E
authors.lastname: Farber
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004351:Drug Resistance / Q000235:genetics* / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D010641:Phenotype; D051381:Rats; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents